The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The Nuclear Factor κ-B Signaling Pathway Participates in Dysregulation of Vascular Smooth Muscle Cells in Vitroand in Human Atherosclerosis
Open accessAbstract
In the lesions of atherosclerosis, vascular smooth muscle cells (SMC) display many functions characteristic of cytokine activation that likely contribute importantly to ongoing inflammation during human atherogenesis. The transcription factor nuclear factor kappa-B (NFkappaB) often mediates the effects of cytokines on target cells, but the identity of Rel family members important in human SMC activation remains uncertain. In vitro, human SMC express multiple Rel family members. Of these, dimers of p65 and p50, but not a putative SMC-Rel, comprise basal and inducible NFkappaB binding activities. SMC express two inhibitor proteins IkappaBbeta and IkappaBalpha. Interleukin-1beta stimulation caused transient loss of IkappaBalpha and a sustained decrease of IkappaBbeta that correlated with increased and persistent levels of p65/p50 protein and binding activity in the nucleus. SMC cultured under serum-free conditions displayed little NFkappaB activity, but addition of serum or platelet-derived growth factor did activate NFkappaB. In situ analyses showed no evidence for basal NFkappaB activity in SMC in vivo as nonatherosclerotic arteries did not contain nuclear p65 or p50 protein. However, the nuclei of intimal SMC within human atheroma did contain both Rel proteins. We conclude that (i) dimers of p65 and p50, but not SMC-Rel, comprise NFkappaB complexes in human SMC; (ii) stimulatory components in serum activate NFkappaB and likely account for previously reported "constitutive" NFkappaB activity in cultured SMC; and (iii) exposure to inflammatory cytokines may produce prolonged NFkappaB activation in SMC because of sustained decreases in the inhibitory subunit IkappaB-beta.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,260
Function and Activation of NF-kappaB in the Immune System
Baeuerle, P. A., & Henkel, T. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.001041 · Cited by 4,745
Schreck, R., Rieber, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,816
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Self-citationRock, K. L., Gramm, C., Rothstein, L., Clark, K., Stein, R., Dick, L., Hwang, D., & Goldberg, A. L. (1994) · Cell · doi:10.1016/s0092-8674(94)90462-6 · Cited by 2,524
Palombella, V. J., Rando, O. J., Goldberg, A. L., & Maniatis, T. (1994) · Cell · doi:10.1016/s0092-8674(94)90482-0 · Cited by 2,096
Structure, Regulation and Function of NF-kappaB
Siebenlist, U., Franzoso, G., & Brown, K. (1994) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.10.110194.002201 · Cited by 2,075
Collins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D., & Maniatis, T. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.10.7542214 · Cited by 1,718
Chen, Z., Hagler, J., Palombella, V. J., Melandri, F., Scherer, D., Ballard, D., & Maniatis, T. (1995) · Genes & Development · doi:10.1101/gad.9.13.1586 · Cited by 1,290
Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion.
Brand, K., Page, S., Rogler, G., Bartsch, A., Brandl, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A., & Neumeier, D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118598 · Cited by 798
IκB-β regulates the persistent response in a biphasic activation of NF-κB
Thompson, J. E., Phillips, R. J., Erdjument-Bromage, H., Tempst, P., & Ghosh, S. (1995) · Cell · doi:10.1016/0092-8674(95)90511-1 · Cited by 751
Li, H., Cybulsky, M. I., Gimbrone, M. A., & Libby, P. (1993) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.13.2.197 · Cited by 689
Self-citationZabel, U., & Baeuerle, P. A. (1990) · Cell · doi:10.1016/0092-8674(90)90806-p · Cited by 430
NF-kappa B and I kappa B alpha: an inducible regulatory system in endothelial activation.
Read, M. A., Whitley, M. Z., Williams, A. J., & Collins, T. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.503 · Cited by 405
Constitutive NF-kB Activity in Neurons
Kaltschmidt, C., Kaltschmidt, B., Neumann, H., Wekerle, H., & Baeuerle, P. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.6.3981-3992.1994 · Cited by 394
Loppnow, H., & Libby, P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114498 · Cited by 375
Self-citationActivation of NF-kappa B in vivo is regulated by multiple phosphorylations.
Naumann, M., & Scheidereit, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06781.x · Cited by 352
Read, M. A., Neish, A. S., Luscinskas, F. W., Palombella, V. J., Maniatis, T., & Collins, T. (1995) · Immunity · doi:10.1016/1074-7613(95)90030-6 · Cited by 347
Functional angiotensin II receptors in cultured vascular smooth muscle cells.
Gunther, S., Alexander, R. W., Atkinson, W. J., & Gimbrone, M. A. (1982) · The Journal of cell biology · doi:10.1083/jcb.92.2.289 · Cited by 346
de Martin, R., Vanhove, B., Cheng, Q., Hofer, E., Csizmadia, V., Winkler, H., & Bach, F. H. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05938.x · Cited by 331
Smooth muscle cells and the pathogenesis of the lesions of atherosclerosis
Raines, E. W., & Ross, R. (1993) · Heart · doi:10.1136/hrt.69.1_suppl.s30 · Cited by 330
Le Bail, O., Schmidt-Ullrich, R., & Israël, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06197.x · Cited by 323
Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus.
Zabel, U., Henkel, T., Silva, M. S., & Baeuerle, P. A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05646.x · Cited by 319
In vivo control of NF-kappa B activation by I kappa B alpha.
Rice, N. R., & Ernst, M. K. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06157.x · Cited by 308
Sustained activation of vascular cells and leukocytes in the rabbit aorta after balloon injury.
Tanaka, H., Sukhova, G. K., Swanson, S. J., Clinton, S. K., Ganz, P., Cybulsky, M. I., & Libby, P. (1993) · Circulation · doi:10.1161/01.cir.88.4.1788 · Cited by 265
Self-citationCulture of quiescent arterial smooth muscle cells in a defined serum‐free medium
Libby, P., & O'Brien, K. V. (1983) · Journal of Cellular Physiology · doi:10.1002/jcp.1041150217 · Cited by 221
Self-citationBellas, R. E., Lee, J. S., & Sonenshein, G. E. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118313 · Cited by 183
Nitric Oxide Attenuates Vascular Smooth Muscle Cell Activation by Interferon-γ
Shin, W. S., Hong, Y., Peng, H., Caterina, R. D., Libby, P., & Liao, J. K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11317 · Cited by 153
Self-citationCytokines and smooth muscle cells in atherosclerosis
Nilsson, J. Å. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.7.1184 · Cited by 121
Dobrzański, P., Ryseck, R.-P., & Bravo, R. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06782.x · Cited by 114
Johnson, D. R., Douglas, I., Jahnke, A., Ghosh, S., & Pober, J. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.27.16317 · Cited by 110
Two distinct mechanisms contribute to the constitutive activation of RelB in lymphoid cells.
Lernbecher, T., Kistler, B., & Wirth, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06723.x · Cited by 88
Vascular smooth muscle cells express a constitutive NF-kappa B-like activity.
Lawrence, R., Chang, L., Siebenlist, U. K., Bressler, P. B., & Sonenshein, G. E. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61994-0 · Cited by 75
Involvement of NF-κB Activation in Thrombin-Induced Human Vascular Smooth Muscle Cell Proliferation
Nakajima, T., Kitajima, I., Shin, H., Takasaki, I., Shigeta, K., Abeyama, K., Yamashita, Y., Tokioka, T., Soejima, Y., & Maruyama, I. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2552 · Cited by 75
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Diabetes-Associated Sustained Activation of the Transcription Factor Nuclear Factor-κB
Bierhaus, A., Schiekofer, S., Schwaninger, M., Andrassy, M., Humpert, P. M., Chen, J., Hong, M., Luther, T., Henle, T., Klöting, I., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.12.2792 · Cited by 824
Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis
Mussbacher, M., Salzmann, M., Brostjan, C., Hoesel, B., Schoergenhofer, C., Datler, H., Hohensinner, P., Basílio, J., Petzelbauer, P., Assinger, A., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00085 · Cited by 596
Metadata
- Authors
- Bourcier, T., Sukhova, G., & Libby, P.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1997-06
- Volume
- 272
- Issue
- 25
- Pages
- 15817-15824
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2020454682
- Cited by
- 263
- References
- 34
- FWCI
- 6.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.